The management of vasospasm associated with traumatic subarachnoid haemorrhage presents many challenges. We present a 20-year-old male admitted after sustaining a closed head injury complicated by a Fisher grade III traumatic subarachnoid haemorrhage. Despite treatment with intravenous nimodipine he developed a delayed ischaemic neurological deficit due to cerebral arterial vasospasm. The vasospasm was successfully managed with serial papaverine angioplasty.
Subarachnoid haemorrhage (SAH) occurs in 15-40% of patients with severe traumatic brain injuries and the presence of subarachnoid blood on the initial CT following brain injury is an independent predictor of poor outcome 1, 2 . The overall incidence of post-traumatic vasospasm is between 10-30% and transcranial Doppler studies suggest it occurs in 60% of patients with traumatic SAH. Vasospasm may occur within hours of the brain injury, but typically presents around day 3, peaks around day 7, and resolves by day 14 3 . Vasospasm in patients with traumatic brain injury is thought to increase mortality at six months by 20% and poor outcome by 40% 4 . It also results in longer ICU and hospital stay and increases cost. Early diagnosis and effective treatment of vasospasm is therefore paramount. Calcium antagonists such as nimodipine are the mainstay of treatment of SAH. Whilst nimodipine does not improve outcome in the general population of patients with traumatic brain injury 5 , in patients with traumatic SAH its use results in a 40% reduction in unfavourable outcome. The benefit is seen mainly in patients with Fisher grade III and IV haemorrhages 6 . Other than treatment with nimodipine, options for the management of patients who develop severe vasospasm due to traumatic SAH are limited. We report a patient who developed severe symptomatic vasospasm following traumatic SAH despite treatment with intravenous nimodipine. The patient was successfully treated with serial papaverine angioplasty.
CASE REPORT
A twenty-year-old male sustained a closed head injury after a fall from a height of two metres. He was unconscious for approximately 10 minutes. On arrival at the local hospital his Glasgow Coma Score (GCS) was 8, his right pupil was fixed and dilated and he was bleeding from his nose and right ear. He was intubated, ventilated and given 20% mannitol 400 ml. Following this treatment his right pupil equalized and became reactive. He was transferred to Royal North Shore Hospital and arrived within six hours of the injury. A cerebral CT scan was performed on arrival ( Figure 1 ).
This demonstrated a Fisher grade III SAH with blood in the suprasellar cistern extending over the tentorium, a fractured right mastoid and a fracture through the floor of the pituitary fossa. An external ventricular drain was inserted for intracranial pressure (ICP) and cerebral perfusion pressure (CPP) monitoring and for therapeutic cerebrospinal fluid (CSF) drainage if needed. Following treatment he was managed in the ICU. He was sedated, ventilated to normocarbia, and commenced on an intravenous (IV) nimodipine infusion at a dose of 20 mcg/kg/min. He was treated with noradrenaline to maintain his CPP above 70 mmHg.
On day 2 a cerebral angiogram was performed to exclude a cerebral aneurysm as the cause of his fall. There was no aneurysm detected, but an intimal tear was seen in the right internal carotid artery. He developed diabetes insipidus that was treated with IV desmopressin acetate. He was weaned from venti-lation and extubated on day 5. At this time he was mildly confused and his GCS was 14. On day 8 he became increasingly confused and agitated. The timing of this neurological deterioration suggested vasospasm as the likely cause and he underwent urgent cerebral angiography under general anaesthesia. The angiogram demonstrated severe right internal carotid artery vasospasm and mild left internal carotid artery vasospasm ( Figure 2 ).
This was effectively treated with selective injection of 720 mg and 600 mg papaverine into the right and left internal carotid arteries respectively ( Figure 3 ).
Systolic arterial blood pressure target was changed from 110-150 mmHg to 140-160 mmHg and blood pressure was maintained at this level with an intravenous infusion of noradrenaline.
The following day a repeat angiogram demonstrated recurrent vasospasm with partial response to papaverine. Balloon angioplasty was considered to be relatively contra-indicated because the vasospasm was adjacent to the carotid dissection. Over the next eight days systolic arterial blood pressure was maintained at 140 to 160 mmHg and in addition the patient underwent daily angiograms under general anaesthetic. He required papaverine for recurrent vasospasm on seven occasions. Between procedures the patient's GCS remained 14. The last angiogram was performed on day 17 at which time the vasospasm had resolved. Oral nimodipine was commenced on day 20 with cessation of IV nimodipine the next day. The remainder of the patient's ICU stay was uneventful. He was discharged to the ward on day 27 and went home one week later.
On discharge from hospital he was fully orientated. His only persistent neurological deficit was right second cranial nerve neuropathy, and bilateral sixth nerve palsies. At one-year follow-up he has returned to his previous employment and further part-time education.
DISCUSSION
We report a patient with severe symptomatic vasospasm following traumatic SAH. Experience of the pathophysiology and treatment of vasospasm comes mostly from patients with aneurysmal SAH. The time course of vasospasm following aneurysmal subarachnoid haemorrhage is well-known, the peak period of onset is day 4 to 7 after the original haemorrhage and resolution generally occurs by day 14. Transcranial Doppler studies suggest that the time course is the same for traumatic subarachnoid 89 haemorrhage 7 . This is not surprising, as it seems likely that the pathophysiology is the same and that vasospasm is cause by the release of haemoglobin breakdown products into the CSF. The increased incidence of poor neurological outcomes following traumatic SAH is presumed to be due to vasospasm. Most research on the treatment of vasospasm has been carried out in patients with aneurysmal SAH, but even in these patients there remains significant controversy over what constitutes optimal treatment. In randomized controlled trials, nimodipine has proven an effective treatment for aneurysmal SAH. Whilst nimodipine does not improve overall outcome in the general population of patients with traumatic brain injury 8 , it does appear effective in patients with SAH visible on their initial CT scan. In the most appropriately designed study to date 9 , its use reduced unfavourable outcomes from 46% to 25% and the benefit was predominantly in those patients with Fisher grade III and 4 haemorrhages, i.e. patients with significant SAH present on the initial CT. The use of nimodipine in patients with traumatic brain injury requires careful monitoring as it is a systemic and cerebral arterial vasodilator. As such it may increase ICP and lower mean arterial pressure and a systemic vasoconstrictor may be necessary to maintain adequate CPP. The other mainstays of the management of vasospasm are maintenance of adequate blood pressure and avoiding hypovolaemia.
CASE REPORT
However, further treatment options are limited if a patient develops worsening cerebral vasospasm in the face of treatment with nimodipine and adequate intravascular volume status. A further option in aneurysmal SAH is therapeutic hypertension. In aneurysmal SAH blood pressure can be increased to increase blood flow through vessels narrowed by vasospasm. However in traumatic SAH, there are often multiple intracranial pathologies and cerebral autoregulation may be lost. In such cases attempts to increase systemic blood pressure may result in an unacceptable increase in intracranial pressure. In such cases an alternative to increasing perfusion pressure across the vasospastic artery is to reduce the resistance to blood flow by performing either chemical (papaverine) or physical (balloon) angioplasty. Selective injection of papaverine into cerebral arteries is also associated with generalized cerebral vasodilatation and may increase intracranial pressure dramatically. Despite this theoretical risk our experience suggests it may be used successfully in patients with traumatic brain injury.
If the vasospasm is resistant to papaverine, balloon angioplasty may be considered. Balloon angioplasty requires greater technical skill than use of papaverine. The balloon can only be manoeuvred into proximal branches of the cerebral arteries and it is most useful in treating severe vasospasm of the vertebrobasilar arteries, the distal internal carotid arteries and proximal middle cerebral arteries. Compared to injecting papaverine, balloon angioplasty carries an increased risk of rupturing the artery being dilated. Its advantage over papaverine is that following successful dilatation vasospasm seldom recurs. But for the presence of the internal carotid artery dissection, our patient would have been an ideal candidate for balloon angioplasty.
Since 1993 we have used papaverine angioplasty in the treatment of vasospasm following aneurysmal SAH. Our standard management is to treat even asymptomatic vasospasm if it results in greater than 50% narrowing of a significant cerebral artery. Papaverine angioplasty is performed daily until the angiogram shows the vasospasm has resolved to the point of being haemodynamically insignificant. This approach has proven to be both clinically and economically effective 10 and we adopted the same approach in this patient with vasospasm due to traumatic SAH. To the best of our knowledge, the use of papaverine angioplasty in the treatment of cerebral vasospasm associated with traumatic SAH has only been reported once previously. This report was in the radiology literature 11 . In that report, the 61-year-old patient had a more severe underlying brain injury associated with a traumatic SAH. The patient was treated with hypertensive, hypervolaemic, haemodilution therapy but not IV nimodipine. Angiograms and subsequent papaverine angioplasty were per-formed only when clinical deterioration occurred. The treatment was associated with a poor initial neurological outcome as the patient developed a left hemiparesis. The patient died from a pulmonary embolus and so the ultimate degree of neurological recovery was unknown.
Our patient had a good initial recovery from traumatic brain injury and despite being treated with nimodipine, developed significant vasospasm on a background of a less severe initial injury. Our patient was successfully managed with daily papaverine angioplasty and made an excellent recovery despite the severe vasospasm. This case report highlights that in selected patients with traumatic SAH, papaverine may be a useful treatment for cerebral arterial vasospasm.
